NanoBio plans nasal vax to prevent UTIs

[Guest guest]

oh dear................so easy to treat yourself with d-mannose when it

is e-coli and/or homeopathy

so disgusting

Sheri

NanoBio plans nasal vax to prevent UTIs

By Maureen o

Comment |

Forward |

Twitter |

Facebook |

LinkedIn

NanoBio has licensed an antigen from the University of Michigan that has

demonstrated the ability to prevent urinary tract infections (UTIs) by

eliminating E. coli bacteria in the urinary tract of mice. UTIs affect 53

percent of women each year; half a million women are hospitalized

annually as a result. And one in five women who develop an infection will

experience recurrence. Although antibiotics clear the infection, there's

currently no therapy to prevent UTIs.

Ann Arbor, MI-based NanoBio plans to combine U of M's antigen with its

own nanoemulsion-based NanoStat adjuvant technology to achieve intranasal

delivery of the treatment. The company already has experience using

NanoStat in clinical trials of its nasal spray flu vaccine.

" E. coli causes nearly 90 percent of all UTIs. It is a common

bacterium and is frequently treated with antibiotics, which has led to

the emergence of drug resistant strains that are difficult to

treat, " stated Harry Mobley, Ph.D., of the University of Michigan's

Department of Microbiology and Immunology. " We previously

anticipated at least ten years of further development of the vaccine

before reaching commercialization; however, partnering with NanoBio and

using their NanoStat technology will significantly accelerate the

development of this long-awaited vaccine. "

- check out

NanoBio's

release

http://www.fiercebiotech.com/press-releases/nanobio-announces-development-nasal-vaccine-prevention-urinary-tract-infect-0

Related Articles:

NanoBio

nabs $6M

vax

grant

NanoBio

inks $54.5M development deal with

GSK

NanoBio tops

up $22M round as it closes in on pact

Read more about:

NanoBio,

nasal

vaccine

Sheri Nakken, former R.N., MA, Hahnemannian

Homeopath

Vaccination Information & Choice Network, Washington State, USA

Vaccines -

http://vaccinationdangers.wordpress.com/ Homeopathy

http://homeopathycures.wordpress.com

Vaccine Dangers, Childhood Disease Classes & Homeopathy

Online/email courses - next classes start April 22

[Guest guest]

oh dear................so easy to treat yourself with d-mannose when it

is e-coli and/or homeopathy

so disgusting

Sheri

NanoBio plans nasal vax to prevent UTIs

By Maureen o

Comment |

Forward |

Twitter |

Facebook |

LinkedIn

NanoBio has licensed an antigen from the University of Michigan that has

demonstrated the ability to prevent urinary tract infections (UTIs) by

eliminating E. coli bacteria in the urinary tract of mice. UTIs affect 53

percent of women each year; half a million women are hospitalized

annually as a result. And one in five women who develop an infection will

experience recurrence. Although antibiotics clear the infection, there's

currently no therapy to prevent UTIs.

Ann Arbor, MI-based NanoBio plans to combine U of M's antigen with its

own nanoemulsion-based NanoStat adjuvant technology to achieve intranasal

delivery of the treatment. The company already has experience using

NanoStat in clinical trials of its nasal spray flu vaccine.

" E. coli causes nearly 90 percent of all UTIs. It is a common

bacterium and is frequently treated with antibiotics, which has led to

the emergence of drug resistant strains that are difficult to

treat, " stated Harry Mobley, Ph.D., of the University of Michigan's

Department of Microbiology and Immunology. " We previously

anticipated at least ten years of further development of the vaccine

before reaching commercialization; however, partnering with NanoBio and

using their NanoStat technology will significantly accelerate the

development of this long-awaited vaccine. "

- check out

NanoBio's

release

http://www.fiercebiotech.com/press-releases/nanobio-announces-development-nasal-vaccine-prevention-urinary-tract-infect-0

Related Articles:

NanoBio

nabs $6M

vax

grant

NanoBio

inks $54.5M development deal with

GSK

NanoBio tops

up $22M round as it closes in on pact

Read more about:

NanoBio,

nasal

vaccine

Sheri Nakken, former R.N., MA, Hahnemannian

Homeopath

Vaccination Information & Choice Network, Washington State, USA

Vaccines -

http://vaccinationdangers.wordpress.com/ Homeopathy

http://homeopathycures.wordpress.com

Vaccine Dangers, Childhood Disease Classes & Homeopathy

Online/email courses - next classes start April 22